Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
Sensing Atrial High Rate Episodes With DX System in Implantable Cardioverter Defibrillators Trial
Status: Enrolling
Updated:  12/31/1969
Einstein Medical Center
mi
from
Philadelphia, PA
Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
Sensing Atrial High Rate Episodes With DX System in Implantable Cardioverter Defibrillators Trial
Status: Enrolling
Updated: 12/31/1969
Einstein Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
Sensing Atrial High Rate Episodes With DX System in Implantable Cardioverter Defibrillators Trial
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)
Sensing Atrial High Rate Episodes With DX System in Implantable Cardioverter Defibrillators Trial
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation
Pilot Study of OFDI Capsule Imaging of the Esophagus of Patients With Atrial Fibrillation Following RF Ablation
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation
Pilot Study of OFDI Capsule Imaging of the Esophagus of Patients With Atrial Fibrillation Following RF Ablation
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Glendale Memorial Hospital and Health Center
mi
from
Glendale, CA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Glendale Memorial Hospital and Health Center
mi
from
Glendale, CA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Regional Cardiology Associates
mi
from
Sacramento, CA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Regional Cardiology Associates
mi
from
Sacramento, CA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Kansas University Medical Center
mi
from
Kansas City, KA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
University of Louisville
mi
from
Louisville, KY
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Cardiology Consultants of East Michigan
mi
from
Flint, MI
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Cardiology Consultants of East Michigan
mi
from
Flint, MI
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Providence Hospital
mi
from
Southfield, MI
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Providence Hospital
mi
from
Southfield, MI
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Jackson Heart Clinic
mi
from
Jackson, MS
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Jackson Heart Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Providence Heart & Vascular Institute
mi
from
Portland, OR
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Providence Heart & Vascular Institute
mi
from
Portland, OR
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Texas Cardiac Arrhythmia
mi
from
Austin, TX
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Texas Cardiac Arrhythmia
mi
from
Austin, TX
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
University of Virginia Medical Center
mi
from
Charlottesville, VA
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
University of Virginia Medical Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital
mi
from
Houston, TX
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
Alert-Based Computerized Decision Support for Stroke Prevention in High-Risk Hospitalized Patients With Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter
Alert-Based Computerized Decision Support for Stroke Prevention in High-Risk Hospitalized Patients With Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation
Prospective, Randomized Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone Versus Hybrid Ablation With Pulmonary Vein Isolation Plus Catheter Ablation for CFAE and Linear Lesions
Status: Enrolling
Updated:  12/31/1969
Aurora Health Care, St. Luke's Medical Center
mi
from
Milwaukee, WI
Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone vs Hybrid Ablation With PVI Plus Catheter Ablation
Prospective, Randomized Comparison of Hybrid Ablation and Pulmonary Vein Isolation Alone Versus Hybrid Ablation With Pulmonary Vein Isolation Plus Catheter Ablation for CFAE and Linear Lesions
Status: Enrolling
Updated: 12/31/1969
Aurora Health Care, St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Status: Enrolling
Updated:  12/31/1969
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Status: Enrolling
Updated: 12/31/1969
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry
Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hospital
mi
from
San Diego, CA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Sharp Memorial Hospital
mi
from
San Diego, CA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
JFK Medical Center
mi
from
Atlantis, FL
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
JFK Medical Center
mi
from
Atlantis, FL
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Florida Hospital Orlando
mi
from
Orlando, FL
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Emory Saint Joseph's Hospital
mi
from
Atlanta, GA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Emory Saint Joseph's Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Texas Cardiac Arrhythmia Research Foundation - St. David's
mi
from
Austin, TX
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Texas Cardiac Arrhythmia Research Foundation - St. David's
mi
from
Austin, TX
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
HeartPlace
mi
from
Bedford, TX
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
HeartPlace
mi
from
Bedford, TX
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Memorial Hermann Medical Center
mi
from
Houston, TX
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Memorial Hermann Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Providence Saint John's Health Center / Pacific Heart Institute
mi
from
Santa Monica, CA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Providence Saint John's Health Center / Pacific Heart Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated:  12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
SMART-SF Radiofrequency Ablation Safety Study
Prospective Safety Assessment of the THERMOCOOL® SMARTTOUCH® SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation
Status: Enrolling
Updated: 12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Huntsville, AL
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Washington Township Medical Foundation
mi
from
Fremont, CA
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Washington Township Medical Foundation
mi
from
Fremont, CA
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Reseda, CA
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Reseda, CA
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Orlando Heart Specialists
mi
from
Altamonte Springs, FL
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Orlando Heart Specialists
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated:  12/31/1969
Elkhart Clinic, LLC
mi
from
Elkhart, IN
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention
Status: Enrolling
Updated: 12/31/1969
Elkhart Clinic, LLC
mi
from
Elkhart, IN
Click here to add this to my saved trials